Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (62)

Latest Posts

About This Stock More About This Stock
Allergan Upgraded To Buy From Neutral At Mizuho
Article By: The Fly
Friday, August 3, 2018 9:31 AM EDT
Mizuho analyst Irina Koffler upgraded Allergan to Buy and raised her price target for the shares to $210 from $194.
In this article: AGN
Read
Pharma Stock Roundup: Mixed Q1 For MRK, PFE, FDA Nod For Kymriah's 2nd Indication
Article By: Zacks Investment Research
Friday, May 4, 2018 8:15 PM EDT
First-quarter results of pharma bigwigs like Pfizer, Merck and Allergan stole the limelight this week. Other than that, Novartis gained FDA approval for the second indication of its CAR-T therapy, Kymriah.
In this article: AGN, JNJ, MRK, NVS, PFE, UTHR, ABBV
Read
Allergan Beats Q1 Earnings, Stock Up
Article By: Zacks Investment Research
Monday, April 30, 2018 12:09 PM EDT
Allergan’s first-quarter earnings of $3.74 per share were above our consensus estimate of $3.36 per share.
In this article: AGN
Read
Should You Buy Allergan Plc When Prices Drop?
Article By: Matthew Hogan
Wednesday, April 4, 2018 4:37 PM EDT
Allergan plc investors have enjoyed seeing the stock price increase by 16.9% over the last month.
In this article: AGN
Read
Allergan Slides After Mylan, Revance Report Deal For Botox Biosimilar
Article By: The Fly
Thursday, March 1, 2018 12:25 PM EDT
Shares of Allergan are under pressure this morning after Mylan and Revance Therapeutics announced an agreement for the development and commercialization of a proposed biosimilar to Botox.
In this article: AGN Also: MYL, RVNC
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Patent Losses Could Sink Allergan
Dean Gilmore 2/5/2018 2:37:30 PM

Look at where $AGN was a year ago. It has lost a chunk of it's value already. This news won't help.

Patent Losses Could Sink Allergan
Alpha Stockman 2/5/2018 2:26:42 PM

These hits all hurt #Allergan's bottom line but aren't it's cash cows like #Botox which still does very well for the company and will only only generate even more revenue over time. $AGN

Patent Losses Could Sink Allergan
Ayelet Wolf 2/5/2018 2:22:51 PM

This news sounds catastrophic to me. Why isn't #Allergan tanking? $AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 4 of 4 comments